the activity of liver disease, hepatocyte proliferation rate and HBV replication level. HBcAg expression patterns in hepatocytes include cytoplasmic expression only, nuclear expression only, both cytoplasmic and nuclear expression, and negative expression. Previous studies indicated differences in HBV nucleocapsid antigen expression patterns may be associated with ALT and liver inflammatory activity or HBV replication level, [6] [7] [8] however, there is still deficiency in a large sample size to substantially support this hypothesis.
In this study, we investigate the relationship between liver HBcAg distribution patterns and hepatic inflammatory activity scores or HBV replication level based upon a large sample size. After statistical analysis, it was found that HBcAg distribution in hepatocytes is associated with liver inflammatory activity or HBV replicative level, which is much of value for clinicians to properly manage patients with chronic hepatitis B.
MATERIALS AND METHODS

Patients
A total of 958 patients with chronic hepatitis B were enrolled into the study. The Ethics Committee Board of Shenzhen Third People's Hospital reviewed and approved this study (2009017) , and written informed consents were obtained from all of them. Nine hundred and fifty-eight cases were diagnosed as chronic hepatitis B according to the diagnostic criteria for chronic hepatitis B established by The Chinese Society of Infectious Diseases and Parasitology, Chinese Medical Association. 9 The inclusion criteria included the followings: age ranging from 14 to 70 years; HBsAg positive for longer than 6 months. The exclusion criteria included coinfection with hepatitis A virus (HAV), hepatitis C virus (HCV), hepatitis D virus (HDV) or hepatitis E virus (HEV); having underlying liver diseases caused by alcohol, drug, autoimmune diseases and so on; HCC; receiving antiviral agents within 6 months.
The 958 cases included 793 males, 165 females, with a mean age of 34.27 years old. The HBcAg expression pattern was analyzed for the relationship with alanine aminotransferase (ALT), serum HBV replication markers, and liver inflammatory activity grade.
Detection of biochemical parameters, serum HBV markers and HBV DNA level Liver function tests including ALT and aspartate aminotransferase (AST), etc, were determined according to the conventional manufacturer's instructions, and HBV serological markers were examined by ELISA (Abbott Company, USA). Serum HBV DNA level was measured by real-time quantitative PCR (ABI 7500, lower limit of detection, 500 copies/ml).
Liver pathology and immunohistochemistry
Liver biopsy was performed with a Menghini needle under the direction of color Doppler ultrasonography, and liver specimens should be required for at least 1.0 centimeter long and consist of more than 10 portal areas. A routine pathological staining (hematoxylin and eosin staining) was conducted according to the conventional manufacture's instructions. Pathological diagnosis for chronic hepatitis B was conducted according to the pathological criterion for chronic hepatitis B established by The Chinese Society of Infectious Diseases and Parasitology, Chinese Medical Association.
9
Liver specimens were fixed in 10% formaldehyde and embedded in paraffin wax according to the routine instructions for histological staining. HBcAg expression in hepatocytes was detected by immunohistochemistry staining using anti-HBc monoclonal antibody (from Shanghai Zhangda Company). Undetectable HBcAg expression was defined as neither nuclear nor cytoplasmic expression of HBcAg in hepatocytes; more than 95% cytoplasmic HBcAg hepatocytes was considered as cytoplasmic expression, more than 95% nuclear HBcAg hepatocytes as nuclear expression, and both cytoplasmic and nuclear HBcAg hepatocytes more than 5% were considered as mixed cytoplasmic and nuclear HBcAg expression.
Statistical analysis
Chi Square tests were conducted to analyze the relationships between HBcAg expression patterns a n d s e r u m A LT, H B V D N A l e v e l s a n d l i v e r necroinflammatory activity scores. All the data were analyzed by χ 2 cutting method (Bonferroni Method) and statistical test level of α was adjusted to 0.05/6 (0.008).
RESULTS
The profiles of ALT, HBV DNA, liver inflammatory activity and HBcAg expression Among the 958 cases, 360 cases presented with ALT ≤40 U/L, 375 cases with 40＜ALT≤80 U/L, 203 cases with 80＜ALT≤400 U/L, 20 cases with higher than 400 U/L. Liver inflammatory scores (Figure 1 ): G 0 , 76 cases (7.9%); G 1 , 649 cases (67.7%); G 2 , 200 cases (20.9%); G 3-4 , 33 cases (3.4%). Liver HBcAg expression profiles (Figure 2 ): 402 cases (42%) with undetectable expression, 178 cases (18.6%) with cytoplasmic expression, 108 cases (11.3%) with nuclear expression, 270 (28.2%) with both cytoplasmic and nuclear expression.
Association of HBcAg distribution and ALT levels
Serum ALT concentrations were divided into 3 gradient levels, ≤40 U/L, 40＜ALT≤80 U/L and 80 ＜ALT≤400 U/L which was shown in Table 1 . It was found that there was a relationship between the ALT levels and the HBcAg expression patterns (χ 2 = 43.23, P＜0.001) .
ALT levels were significantly different among patients with undetectable HBcAg and cytoplasmic, undetectable and cytoplasmic/nuclear, cytoplasmic/ nuclear, nuclear and mixed cytoplasmic and nuclear HBcAg expression, χ 2 = 16.46, 28.96, 13.52, 19.68, respectively; and all the P values were less than 0.001 as shown in Table 1 . However, there were no significant differences among the patients with negative, nuclear, 
Association between liver HBcAg distribution and inflammatory activity grades
The patients with different HBcAg distribution types were divided into 4 groups according to different liver inflammatory activity scores as shown in Table 2 . Chi Square test indicated a relationship between HBcAg expression and liver inflammatory activity scores (χ 2 = 74.93, P ＜ 0.001). This suggested that liver necroinflammatory activity scores were significantly different among the patients with different HBcAg expression patterns.
Liver inflammatory activity scores were significantly different among the different groups such as negative and cytoplasmic HBcAg expression, negative and cytoplasmic in combination with nuclear HBcAg expression, cytoplasmic and nuclear HBcAg expression, nuclear and cytoplasmic in combination with nuclear HBcAg expression, respectively, χ 2 = 47.81 (P < 0.001), 50.19 (P < 0.001), 21.13 (P < 0.001), 16.98 (P = 0.001), and all the P values ＜0.001 as shown in Table  2 . However, the liver inflammatory activity scores were not significantly different among the patients between negative and nuclear HBcAg expression, cytoplasmic HBcAg expression and cytoplasmic in combination with nuclear HBcAg expression, χ 2 = 10.85 (P = 0.013) and 5.63 (P = 0.131), respectively. Among the patients with nuclear HBcAg expression, liver inflammatory activity were mostly G 0 and G 1 , consisting of 15.7% (G 0 ) and 75.9% (G 1 ), respectively, and 8.4% (G 2 -G 4 ). With regard to patients with both nuclear and cytoplasmic HBcAg expression, liver inflammatory activity were mainly from G 1 and G 2 , accounting for 65.9% and 21.9%, respectively. In terms of cytoplasmic expression, G 1 and G 2 accounted for the majority, with G 2 40.4% and G 0 2.8%. The liver inflammatory activity of patients with negative HBcAg expression were at a lower level, which was similar to that of patients with nuclear HBcAg expression.
Association between HBcAg expression and HBeAg status As shown in Table 3 . However, there was no significant difference between nuclear HBcAg expression and cytoplasmic in combination with nuclear HBcAg expression, χ 2 = 2.826 (P = 0.093). The percentage of serum HBeAg positivity were 88% in patients with nuclear HBcAg expression, 80.7% with cytoplasmic in combination with nuclear HBcAg expression, 40.8% with cytoplasmic HBcAg expression and 14.7% with negative HBcAg expression.
Association of HBcAg distribution and HBV DNA viral load
It was found that there was a relationship between liver HBcAg expression and serum HBV DNA level through Chi Square tests, χ 2 = 417.41, P＜0.001. The serum HBV DNA levels were significantly different between patients with negative HBcAg expression and cytoplasmic HBcAg expression, negative and nuclear HBcAg expression, negative and cytoplasmic in combination with nuclear HBcAg expression, cytoplasmic and nuclear HBcAg expression, cytoplasmic and cytoplasmic in combination with nuclear HBcAg expression, with χ 2 = 132.00, 230.31, 311.49, 30.23, 32.51, respectively, and all the P values＜0.001. However, there was no significant difference between nuclear HBcAg expression and cytoplasmic combined with nuclear HBcAg expression, χ 2 = 3.893 (P = 0.273) as shown in Table 4 .
Serum HBV DNA levels were the highest in patients with HBcAg nuclear expression in hepatocytes, with 86.0% patients higher than 1 × 10 6 copies/ml, 1.9% lower than 5 × 10 2 copies/ml, 77.4% patients with both cytoplasmic and nuclear HBcAg expression had HBV DNA higher than 1 × 10 6 copies/ml, 2.3% lower than 5 × 10 2 copies/ml. 54.3% patients with cytoplasmic HBcAg expression had HBV DNA ＞1 × 10 6 copies/ml, 8.0% with HBV DNA ＜5 × 10 2 copies/ml, only 12.3% patients with negative HBcAg expression having HBV DNA ＞ 1 × 10 6 copies/ml, 38.6% with HBV DNA ＜5 × 10 2 copies/ml.
DISCUSSION
ALT is located in hepatocyte cytoplasmic membrane and a sensitive serological marker for assessing liver injury or liver necroinflammatory activity, 10 and can also reflect the extent to host immune response to HBV.
11 Clinically, if ALT levels of patients with chronic hepatitis B (CHB) are higher than 2 times of upper limit of normal, patients should be treated with antiviral agents such as interferonalpha or nucleos(t)ide analogues. However, normal ALT levels usually represent immune tolerance to HBV. In this study, we found that liver HBcAg expression patterns correlate with ALT levels, liver inflammatory activity scores, and HBV replication markers of serum HBeAg and HBV DNA viral loads based on a large sample size. Ozer et al reported that higher serum HBV DNA correlated with increased hepatocyte HBcAg expression. 12 Chu et al found that patients with cytoplasmic HBcAg expression exhibited a higher ALT level and histological inflammatory activity compared with those patients with nuclear HBcAg expression.
13-15
The degree of expression of HBcAg in the hepatocyte nucleus but not the cytoplasm can accurately reflect the level of viral replication in patients with chronic hepatitis B.
16
Association of serum ALT and liver HBcAg distribution was confirmed by the association between liver inflammatory activity grades and HBcAg expression patterns. Nuclear HBcAg expression and negative expression were mostly characterized by normal or low ALT level or lower liver inflammatory activity scores, with half of CHB patients' ALT levels being normal. However, patients with cytoplasmic HBcAg expression or nuclear in combination with cytoplasmic HBcAg expression displayed higher ALT levels compared with nuclear or negative HBcAg expression, ALT＞80 U/L accounting for 28%. Similarly, after analysis of HBcAg expression and liver inflammatory activity scores, we got similar results that cytoplasmic HBcAg expression correlated with the highest liver inflammatory activity scores, nearly half of patients were more than G 2 ; the majority of CHB patients with nuclear HBcAg expression exhibited lower liver inflammatory activity scores of G 0 and G 1 ; patients with nuclear combined with cytoplasmic HBcAg expression were in the middle of liver inflammatory activity scores.
With regards to the relationship between HBcAg expression patterns and HBV replicative markers of serum HBV DNA viral load and serum HBeAg status, it was found that HBcAg expression patterns correlated with serum HBV DNA level and HBeAg status. Nuclear HBcAg expression or nuclear in combination with cytoplasmic HBcAg expression were accompanied with a higher percentage of HBeAg positivity and higher serum HBV DNA level. On the other hand, cytoplasmic HBcAg expression or negative HBcAg expression were associated with lower HBV DNA level and lower rate of serum HBeAg positivity. The HBcAg expression patterns can also reflect different host immune responses to HBV, cytoplasmic HBcAg expression or negative HBcAg expression indicates host immune clearance to HBV, and nuclear HBcAg expression represents host immune tolerance to HBV. With HBcAg migration from nuclear to cytoplasm until HBcAg clearance, patient immune response to HBV can gradually be enhanced, and some patients may result in HBV elimination. 17, 18 Taken together, our study suggests that HBcAg expression patterns are associated with patient immune responses to HBV, liver inflammatory activity and viral replication level, which can help clinicians properly guide the management of patients.
